🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary Objective: To assess the tolerability and safety of SAR438544 afte...
Status
Completed
Location
Investigational Site Number 840001
Start Date
2015-12
Trial ID
NCT02625636
Treatments Being Tested
The aim of this study is to evaluate the growth hormone (GH) and adrenocort...
Status
Completed
Location
Multiple Locations
Start Date
2011-09
Trial ID
NCT02240043
Treatments Being Tested
Primary Objective: To assess the pharmacodynamic response (PD) of a single...
Status
Withdrawn
Location
Multiple Locations
Start Date
2016-04
Trial ID
NCT02635243
Treatments Being Tested
This is a single centre, double-blind, randomised, three-period crossover p...
Status
Completed
Location
Profil Institut für Stoffwechselforschung GmbH
Start Date
2017-06-06
Trial ID
NCT03176524
Treatments Being Tested
The trial's objective is to evaluate the immunogenicity of repeated single ...
Status
Completed
Location
Compass Research
Start Date
2017-06-28
Trial ID
NCT03216226
Treatments Being Tested
The objective of the trial is to demonstrate superiority of dasiglucagon co...
Status
Completed
Location
ProSciento
Start Date
2017-12-07
Trial ID
NCT03378635
Treatments Being Tested
Primary Objective: To demonstrate bioequivalence between insulin glulisine...
Status
Completed
Location
Investigational Site Number 276001
Start Date
2017-02-17
Trial ID
NCT02910518
Treatments Being Tested
This is a multi-center, randomized, controlled, single-blind, two-way cross...
Status
Completed
Location
Diablo Clinical Research
Start Date
2018-09-27
Trial ID
NCT03738865
Treatments Being Tested
This study provides information on immunogenicity of Nasal Glucagon (AMG504...
Status
Completed
Location
Algorithme Pharma Inc.
Start Date
2013-09
Trial ID
NCT01959334
Treatments Being Tested
A phase 3, randomized, double-blind, placebo- and active-controlled, parall...
Status
Completed
Location
AMCR Institute, Inc
Start Date
2018-09-28
Trial ID
NCT03667053
Treatments Being Tested